Robert Whitfield MD outlines a diagnostic protocol for breast implant illness that tests genetics, liver and kidney function, inflammatory markers, sex hormones, gut health, and toxic exposures like heavy metals and mycotoxins. The evaluation supports patients before and after explant surgery.
We look at, once again, our heart program, which is really evaluation of genetics. It looks at all of your blood work, including your liver and kidney function, your blood counts, your inflammatory markers, your thyroid and your other hormone functions, including estrogen, progesterone, testosterone. We look at food sensitivities and stool testing to really try to evaluate how we can decrease inflammation in the gut. We also look at other biomarkers for inflammation. And then we look at toxicity, both environmental toxins, heavy metals, and then, of course, mycotoxins. So mycotoxins play a big role. I see a lot of this in my patients with bii. And I think it's really important to use a comprehensive approach to evaluate the client and encourage them that, you know, we appreciate and understand what they're going through. And we've designed this program to really help them before, during, and after surgery in their explant.
